v3.26.1
Schedule Of Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Dec. 27, 2025
Disposal Group, Including Discontinued Operations [Line Items]      
Other assets $ 15,983   $ 15,983
Total current liabilities from discontinued operations 1,579   2,554
Property and equipment, gross 65   65
Less accumulated depreciation (39)   (37)
Intangible assets 27,594   27,659
Less accumulated amortization (5,441)   (4,619)
Net (loss) income from discontinued operations (177) $ (480)  
Depreciation and amortization 889 1,210  
Accounts payable & accrued liabilities (1,464) (332)  
Net cash provided by operating activities from discontinued operations  
Net cash used in investing activities from discontinued operations  
Net cash used in financing activities from discontinued operations  
Effect of changes in exchange rate on cash and cash equivalents 8,077 3,633  
DECREASE IN CASH AND CASH EQUIVALENTS 4,300 3,754  
CASH AND CASH EQUIVALENTS, beginning of period 6,222 7,177  
Equipment [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Property and equipment, gross 43   43
Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Other current assets 192   205
Total current assets from discontinued operations 192   205
Total property and equipment, net, from discontinued operations [1] 1,170   1,170
Total accrued expenses [2] 13,826   13,826
Deferred income taxes 776   776
Other assets 211   211
Total other assets from discontinued operations 15,983   15,983
Total assets from discontinued operations 16,174   16,188
Accounts payable 79   54
Other [3] 1,500   2,500
Total current liabilities from discontinued operations 1,579   2,554
Total noncurrent liabilities from discontinued operations  
Total liabilities from discontinued operations 1,579   2,554
Property and equipment, gross 1,170   1,170
Less accumulated depreciation  
Intangible assets 19,293   19,293
Less accumulated amortization (5,467)   (5,467)
Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member] | Soin Intangible [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Intangible assets 19,293   19,293
Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member] | Building Improvements [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Property and equipment, gross  
Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member] | Equipment [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Property and equipment, gross  
Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member] | Construction in Progress [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Property and equipment, gross 1,170   1,170
Discontinued Operations [Member] | Soin Therapeutics LLC [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Total accrued expenses 1,500   2,500
Discontinued Operations [Member] | Soin Therapeutics LLC [Member] | Dr Soin [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Other 1,500   2,500
Discontinued Operations [Member] | Soin Therapeutics LLC [Member] | Other Counterparty [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Other  
Discontinued Operations [Member] | Biotech Segment [Member]      
Disposal Group, Including Discontinued Operations [Line Items]      
Revenues  
Cost of revenues  
Gross profit  
Selling, general and administrative expenses 177 540  
Total operating expenses from discontinued operations 177 540  
Operating loss from discontinued operations (177) (540)  
Total other expense, net  
Loss before provision for income taxes from discontinued operations (177) (540)  
Income tax provision benefit 60  
Net (loss) income from discontinued operations (177) (480)  
Depreciation and amortization 2,087  
Noncash expense (benefit) funded by parent 1,138 (2,820)  
Accounts payable & accrued liabilities (961)  
Net cash provided by operating activities from discontinued operations (1,213)  
Net cash used in investing activities from discontinued operations  
Net cash used in financing activities from discontinued operations  
Effect of changes in exchange rate on cash and cash equivalents  
DECREASE IN CASH AND CASH EQUIVALENTS  
CASH AND CASH EQUIVALENTS, beginning of period  
CASH AND CASH EQUIVALENTS, end of period  
[1] The Company’s property and equipment consisted of the following (in $000s):
[2] The Company’s intangible assets consisted of the following:
[3] The Company’s accrued liabilities consisted of the following: